Intra-cellular therapies announces presentations at psych congress 2023 including positive results from study 403 in mixed features

New york, sept. 11, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced several caplyta data presentations at the 2023 psych congress held september 6 - 10, 2023 in nashville.
ITCI Ratings Summary
ITCI Quant Ranking